Atomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD). It is sold in the form of the hydrochloride salt of atomoxetine. Atomoxetine is a selective norepinephrine re-uptake inhibitor. It appears to work by blocking or slowing the reabsorption of norepinephrine...
Strattera (atomoxetine hcl) is approved for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children aged 6 and older, teens, and adults. Strattera should be used as part of a total treatment program for ADHD that may include counseling or other therapies...
In a model of rats trained to self-administer cocaine, researchers found that efficacy of treatments to control drug-seeking behavior depended on the subject's phase of addiction.
Family history is a greater risk factor than lifestyle for developing some cancers, according to a Swedish study looking at 71,000 adopted people.
A new study suggests that for older patients with type 2 diabetes, the negative effects of treatment with insulin pills or injections may outweigh the benefits.